Pfizer Revenue, Growth & Competitor Profile

DBA WYETH

Company Profile & Annual Report for Pfizer

Access the complete profile.

Pfizer Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	Over 1,000Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 5417 Scientific Research & Development Services
Address	66 Hudson Blvd East New York, NY 10001

Pfizer's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Pfizer's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Pfizer is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Pfizer is a publicly traded company on NYQ using the ticker symbol PFE. Detailed information on company financials and operating reports can be found here: NYQ: PFE

Pfizer Annual Revenue and Growth Rate

Pfizer	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	Over $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Pfizer's revenues are gauged from an analysis of company filings.

Trademark Applications

Trademark applications show the products and services that Pfizer is developing and marketing. Pfizer doesn't have any recent trademark applications, indicating Pfizer is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
LET'S OUTDO CANCER Providing information on the topic of cancer; online information services, namely providing a website on the topic of cancer.	01/23/2024
GROW OUT LOUD Medical information services, namely, providing information on the topic of Alopecia Areata and the treatment of Alopecia Areata; online information services, namely, providing information on the topic of Alopecia Areata and the treatment of Alopecia Areata	01/10/2024
HEMEKRYS Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; Pharmaceutical preparations for the treatment of sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions	01/10/2024

See all trademarks and details in the Full Report.

Market Share of Pfizer's Largest Competitors

A competitive analysis shows these companies are in the same general field as Pfizer, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Pfizer. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
PFIZER	New York, NY	100
SUMITOVANT BIOPHARMA	New York, NY	3
ROIVANT SCIENCES	New York, NY	2
TERRASCEND USA	New York, NY	1
KADMON HOLDINGS	New York, NY	0
CALLIDITAS NA ENTERPRISES	New York, NY	0

Future Competition: Pfizer's Fastest Growing Competitors

These companies are in the same general field as Pfizer and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)